Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0675033B2 - Optical measuring method of biological tissue and light source device for measuring the same - Google Patents
[go: Go Back, main page]

JPH0675033B2 - Optical measuring method of biological tissue and light source device for measuring the same - Google Patents

Optical measuring method of biological tissue and light source device for measuring the same

Info

Publication number
JPH0675033B2
JPH0675033B2 JP14781890A JP14781890A JPH0675033B2 JP H0675033 B2 JPH0675033 B2 JP H0675033B2 JP 14781890 A JP14781890 A JP 14781890A JP 14781890 A JP14781890 A JP 14781890A JP H0675033 B2 JPH0675033 B2 JP H0675033B2
Authority
JP
Japan
Prior art keywords
light
light source
biological tissue
measuring
wavelength
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP14781890A
Other languages
Japanese (ja)
Other versions
JPH0440341A (en
Inventor
達男 横塚
征夫 笠原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Priority to JP14781890A priority Critical patent/JPH0675033B2/en
Publication of JPH0440341A publication Critical patent/JPH0440341A/en
Publication of JPH0675033B2 publication Critical patent/JPH0675033B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Semiconductor Lasers (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は医療診断方法の内、光学的に生体組織を計測す
る生体組織の光学的計測方法及びその計測用光源装置に
関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for optically measuring a living tissue, which optically measures the living tissue, and a light source device for the measurement, among medical diagnostic methods.

従来の技術 最近、外部より損傷を与えない(悲観血的)生体内部の
観測技術の開発が進んでいる。即ち、この観測技術は、
生体組織による光の散乱、吸収、発光は、各組織により
特徴的な波長依存性(分散関係)がある性質を利用した
もので、この観測方法はX線CTや超音波CTなどの観測技
術において、X線、超音波の代わりに、観測のプルーブ
を用いたものである。つまり、光と呼ばれる電磁波の中
で、特に赤外領域の光は生体組織に対して良好な透光性
を示すから、この種の光を用いることにより、光を使用
したCTが可能になる。
2. Description of the Related Art Recently, a technique for observing the inside of a living body that does not damage externally (pessimistic blood) has been developed. That is, this observation technology
The scattering, absorption, and emission of light by living tissues utilize the characteristic that each tissue has a characteristic wavelength dependence (dispersion relationship). This observation method is used in observation techniques such as X-ray CT and ultrasonic CT. , The probe of observation was used instead of the X-ray and the ultrasonic wave. In other words, among electromagnetic waves called light, light in the infrared region in particular shows good translucency to living tissue, and therefore, using this kind of light, CT using light becomes possible.

第2図はファイバ・コリメータを用いた従来の生体内酸
素濃度の2次元走査システムを示す。
FIG. 2 shows a conventional two-dimensional scanning system for oxygen concentration in a living body using a fiber collimator.

第2図において、1は後述する半導体レーザ及びHe−Ne
レーザを用いた光源、2はその光源1のレーザ光を対象
物3に導く光ファイバー、4は対象物3からのレーザ光
を受光して導く光ファイバー、5,6は光ファイバーから
の光を検出して光電変換等を行なう検出器及び前処理回
路である。7は前処理回路6の出力するアナログ検出信
号をデジタル信号に変換するA/D変換器、8はその出力
をインターフェイス9を介して特性分布を解析するコン
ピュータ、10はそのモニターである。11はモーター12を
介して光ファイバー2,4を2次元に駆動するモータード
ライバーである。なお、前処理回路6は半導体レーザと
He−Neレーザに対応して2系統が設けられており、モー
ター12もx,y方向に対応して2系統が設けられている。
In FIG. 2, 1 is a semiconductor laser and He-Ne which will be described later.
A light source 2 using a laser, 2 is an optical fiber that guides the laser light of the light source 1 to the object 3, 4 is an optical fiber that receives and guides the laser light from the object 3, and 5 and 6 detect light from the optical fiber. A detector and a preprocessing circuit for performing photoelectric conversion and the like. Reference numeral 7 is an A / D converter for converting the analog detection signal output from the pre-processing circuit 6 into a digital signal, 8 is a computer for analyzing the characteristic distribution of the output through the interface 9, and 10 is its monitor. Reference numeral 11 is a motor driver that drives the optical fibers 2 and 4 in two dimensions via the motor 12. The preprocessing circuit 6 is a semiconductor laser.
Two systems are provided corresponding to the He-Ne laser, and two motors 12 are also provided corresponding to the x and y directions.

さて、この2次元走査システムでは、光源として、発振
波長が780mmのA1GaAs/GaAs系の半導体レーザと、同じく
632.8mmのHe−Neレーザを用いている。したがって、フ
ァイバ・コリメータを2次元面内で走査することによっ
て、光の吸収分布が計測されるが、光の吸収の波長依存
によって、例えば脂肪と腫瘍組織の区別ができ、その分
布が得られる。しかしながら、前述した2つの光源を用
いた場合の波長依存性は、散乱の波長依存性であるか
ら、コントラストがつきにくいという難点がある。
Now, in this two-dimensional scanning system, the light source is the same as the A1GaAs / GaAs semiconductor laser with an oscillation wavelength of 780 mm.
A 632.8 mm He-Ne laser is used. Therefore, although the absorption distribution of light is measured by scanning the fiber collimator in a two-dimensional plane, for example, fat and tumor tissue can be distinguished and the distribution can be obtained depending on the wavelength dependence of the absorption of light. However, the wavelength dependence when the two light sources described above are used is the wavelength dependence of scattering, and therefore there is a drawback that it is difficult to obtain contrast.

ところで、生体系の分光測定は、本質的に散乱体を含む
不均一系の分光計測として取り扱える。つまり、光を生
体内を透過させたとき、透過率の波長依存性は散乱と吸
収とによるもので、それらの寄与は互いに独立であると
して扱える。生体組織を構成している、水、脂肪、タン
パク質などの物質は、可視から赤外線の波長領域に亙っ
て、それぞれの物質に特有な吸収線(帯)を持つ。ま
た、タンパク質においても、多くの種類ごとにそれぞれ
特有の吸収線を有し、これを利用して生体組織の同定が
可能である。
By the way, the spectroscopic measurement of a biological system can be treated as a spectroscopic measurement of a heterogeneous system essentially including a scatterer. That is, when light is transmitted through the living body, the wavelength dependence of the transmittance is due to scattering and absorption, and their contributions can be treated as being independent of each other. Substances such as water, fat, and proteins that make up biological tissues have absorption lines (bands) peculiar to each substance in the visible to infrared wavelength range. In addition, proteins also have absorption lines that are unique to each of many types, and it is possible to identify living tissues by utilizing these absorption lines.

タンパク質を例にして、その測定方法を説明すると、目
的の吸収線の波長と、その極近傍の波長の吸収率を比較
することで、目的のタンパク質の存在量、分布の知見が
原理的に得られる。吸収線は、一般に各タンパク質ごと
に複数あるため、複数の波長点で測定することで、濃
度、分布の測定精度が向上する。さらに、測定波長を走
査できれば、吸収体の形状が分かり、吸収率の測定精度
が向上を期待できる。また、光の吸収後の各物質で特有
の発光においても、同様な組成の同定、分布の知見が得
られる。
Using a protein as an example, the measurement method is explained.By comparing the absorption rate at the wavelength of the desired absorption line with the absorption rate at the wavelength in the immediate vicinity, we can theoretically obtain knowledge of the abundance and distribution of the desired protein. To be Since there are generally a plurality of absorption lines for each protein, measuring at a plurality of wavelength points improves the measurement accuracy of concentration and distribution. Further, if the measurement wavelength can be scanned, the shape of the absorber can be known, and the accuracy of measuring the absorptance can be expected to improve. Further, even in the light emission peculiar to each substance after absorbing light, similar identification of composition and knowledge of distribution can be obtained.

また、生体は完全散乱体であるけれども、光の散乱は主
としてレーリー散乱の寄与が大きく、また、多重散乱が
一回散乱より支配的であり、経験的には波長の逆数の4
から6乗に比例する散乱係数を示す。光の散乱の分散関
係を利用し、複数の波長の光を用いた例では、腫瘍組織
の検出、組織内の酸素濃度分布測定が知られている。
Although living organisms are perfect scatterers, Rayleigh scattering is a major contributor to light scattering, and multiple scattering is more dominant than single scattering. Empirically, the reciprocal of the wavelength is 4
The scattering coefficient proportional to the 6th power is shown. In the example of utilizing the dispersion relation of light scattering and using light of a plurality of wavelengths, detection of tumor tissue and measurement of oxygen concentration distribution in the tissue are known.

吸収率の測定を行う際は、単純には波長が長い領域に存
在する吸収線の測定の方が、波長が短い領域の吸収線よ
りも、散乱による光の減衰の効果が減って有利になる。
例えば、波長600nmと1000nmでは光の透過量は10程度の
差がある。
When measuring the absorptance, simply measuring the absorption line existing in the long wavelength region is more advantageous than measuring the absorption line in the short wavelength region because the effect of light attenuation due to scattering is reduced. .
For example, there is a difference of about 10 in the amount of transmitted light between wavelengths of 600 nm and 1000 nm.

ところが、光を微小口径(<1mm)に絞って、透過光を
検出する場合には、状況が異なる。この測定の場合、光
は散乱を受けながら、一方では特定の波長の光はタンパ
ク質、水、脂肪で特定の波長の吸収が起こるが、入射し
た方向を保った光、直進した光はそれらの物質で吸収を
受けない。反対に、散乱を受けた光は光路が長くなるた
めに、吸収される割合が高く、その強度が減少する。こ
の結果、吸収線近傍の波長を持つ光は、入射した後、ほ
とんど広がらずに反対側から出射するような強度分布を
持つ。この性質を利用することで、光を測定体上を走査
(スキャン)し、2次元、3次元的な分布の状態の知見
を得ることができ、原理的にいえば、光学CTへの応用が
可能である。詳細にいえば、測定体を透過してきた光を
検出できるなら、波長はできるだけ短い方が、光の広が
りが少なく、空間分解能がよい。ただし、空間分解能を
よくするには、散乱による光の強度の減衰が大きくなる
ため、測定に際してのそれぞれの最適条件の波長があ
る。
However, the situation is different when the transmitted light is detected by narrowing the light to a small aperture (<1 mm). In the case of this measurement, while light is scattered, light of a specific wavelength is absorbed by proteins, water, and fat at a specific wavelength, but the light that keeps the incident direction and the light that goes straight are those substances. Not absorbed by. On the contrary, the scattered light has a long optical path, so that it is highly absorbed and its intensity decreases. As a result, the light having a wavelength in the vicinity of the absorption line has an intensity distribution in which after entering, the light hardly spreads and then exits from the opposite side. By utilizing this property, it is possible to scan light on the measurement object and obtain knowledge of the state of two-dimensional and three-dimensional distribution. In principle, it can be applied to optical CT. It is possible. In detail, if the light transmitted through the measurement object can be detected, the shorter the wavelength, the smaller the spread of the light and the better the spatial resolution. However, in order to improve the spatial resolution, attenuation of light intensity due to scattering becomes large, so that there is a wavelength under each optimum condition at the time of measurement.

以上に述べたように、光を用いた生体の“そのままの観
察”では、可視から近赤外光が非常に重要な役割を果た
そうとしている。
As described above, in the "as-is observation" of a living body using light, visible to near-infrared light is going to play a very important role.

発明が解決しようとする課題 前述した生体の観察・測定を行う際には、500〜1500nm
の間の波長光で可変でありかつ輝度の高い光源(例えば
単一波長発振のレーザであれば5〜20mw程度)が必要で
あるが、現状では、適当な光源が無かった。即ち、ハロ
ゲン光などの白色光を分光器で分光して用いる場合に
は、分光後の光の輝度が低く、測定に時間がかかった
り、十分な分解能が得られない。そこで、輝度(パワー
密度)の高いレーザが注目されているけれども、一般的
に知られている固体、ガスレーザでは波長が固定されて
いるため、波長を代える測定には適切ではない。また、
従来の色素レーザの場合には、波長の走査範囲が狭く、
色素の種類を多数変える必要もあり、また色素の寿命が
一般に短く、これも適切とはいえない。さらに、固体、
ガス、色素レーザは大型(100kg以上)かつ高価である
といった難点もある。
Problems to be Solved by the Invention When observing and measuring a living body as described above, 500 to 1500 nm
It is necessary to use a light source which is variable and has a high brightness (for example, a laser of single wavelength oscillation has a wavelength of about 5 to 20 mw) in the wavelength range between the two. However, at present, there is no suitable light source. That is, when white light such as halogen light is used after being separated by a spectroscope, the brightness of the light after the separation is low, the measurement takes time, and sufficient resolution cannot be obtained. Therefore, although lasers with high brightness (power density) are attracting attention, generally known solid-state and gas lasers have fixed wavelengths, and thus are not suitable for measurement with different wavelengths. Also,
In the case of conventional dye laser, the scanning range of wavelength is narrow,
It is necessary to change many kinds of dyes, and the life of dyes is generally short, which is not appropriate. In addition, solid,
Gas and dye lasers also have the drawback of being large (100 kg or more) and expensive.

これに対して、半導体レーザは、発振波長の範囲が広
く、小型(通常1g以下)、低消費電力の性質と併せて、
目的に合っている。
On the other hand, a semiconductor laser has a wide oscillation wavelength range, is small (usually 1 g or less), and has low power consumption.
It fits the purpose.

半導体レーザにつき検討すると、現在、実用化されてい
る半導体レーザは、大きく3つの種類に分類できる。つ
まり、これらの種類は、A1GaAs/GaAs系、InGaAsP/InP
系、そしてA1GaInP/GaAs系であるが、発振波長の範囲は
それぞれ780〜900nm1、100〜1600nm5、80〜670nmの範囲
内にある。
When semiconductor lasers are examined, currently available semiconductor lasers can be roughly classified into three types. In other words, these types are A1GaAs / GaAs system, InGaAsP / InP
System and A1GaInP / GaAs system, but the oscillation wavelength ranges are 780 to 900 nm1, 100 to 1600 nm5, and 80 to 670 nm, respectively.

しかしながら、従来の半導体レーザは、 1)生体組織測定で使用頻度が高い900〜1100nmの波長
領域が空白になっていること 2)発振波長は素子の活性層の組成、もしくは構造によ
って変化できるが、それぞれの素子ごとに決まってお
り、電流注入などの外的操作条件では大きく変化できな
いこと の2つの課題があった。
However, in the conventional semiconductor laser, 1) the wavelength region of 900 to 1100 nm, which is frequently used in biological tissue measurement, is blank. 2) The oscillation wavelength can be changed depending on the composition or structure of the active layer of the device. It was decided for each element, and there were two problems: it could not be changed significantly under external operating conditions such as current injection.

加えると、従来の半導体レーザでは、一つの素子では広
範囲に波長は変えられないので、波長を操作する代わり
に、複数の半導体レーザ素子を用いることになるけれど
も、多数の素子を用いると、素子を変更するごとに、例
えば面倒な光軸の調整が必要になる。
In addition, in the conventional semiconductor laser, the wavelength cannot be changed in a wide range with one element, so a plurality of semiconductor laser elements are used instead of operating the wavelength. For each change, for example, a troublesome adjustment of the optical axis is required.

課題を解決するための手段 前述した課題を解決するため、本発明では、次のような
技術的解決手段をとる。即ち、 1)基板がGaAsであり、クラッド層、オーミックコンタ
クト層の材料は基板と格子整合するA1xGa1-xAsであり、
活性層を構成する材料が基板と格子不整合であるGaxIn
1-xAs(0≦x≦0.5)を用いた半導体レーザを、光源と
して使用する。この半導体レーザは活性層の組成Xを変
化させることで、780〜1100nmまでの間の発振波長が得
られる。
Means for Solving the Problems In order to solve the problems described above, the present invention takes the following technical solutions. That is, 1) the substrate is GaAs, and the material of the clad layer and the ohmic contact layer is A1xGa1 - xAs that lattice-matches with the substrate,
GaxIn in which the material forming the active layer has a lattice mismatch with the substrate
A semiconductor laser using 1- xAs (0 ≦ x ≦ 0.5) is used as a light source. This semiconductor laser can obtain an oscillation wavelength between 780 and 1100 nm by changing the composition X of the active layer.

2)複数のレーザ素子を用いる代わりに、マルチストラ
イブ型のレーザを用いて、これを光源とする。このレー
ザでは、前述したGaInAs/A1GaAs系のレーザの活性層のG
axIn1-xAsのIn組成をストライプごとに変えられる。即
ち、このようなストライプ構造では、ストライプ間で発
振波長が異なるため、不連続であるが、異なった発振波
長での走査が可能になる。つまり、ストライプ間の間隔
を200μm程度にできるため、光軸の調整は、不要もし
くは微少になり、光学系が非常に簡単になる。
2) Instead of using a plurality of laser elements, a multi-stripe type laser is used as a light source. In this laser, the G of the active layer of the GaInAs / A1GaAs system laser described above
The In composition of axIn 1- xAs can be changed for each stripe. That is, in such a stripe structure, since the oscillation wavelengths are different between the stripes, it is possible to perform scanning at different oscillation wavelengths although they are discontinuous. That is, since the distance between the stripes can be set to about 200 μm, the adjustment of the optical axis becomes unnecessary or insignificant, and the optical system becomes very simple.

作 用 前述した本発明の構成によると、可視から近赤外光領域
での波長の異なった複数のレーザ光の走査による生体内
組織の物質の同定と、その分布の測定を容易になる。ま
た、このような計測方法によれば、現状に対して、同定
出来る物質の種類の拡大が図れ、また組織の分布測定で
は、空間分解能の向上、また測定の時間の短縮が図れ
る。
Operation According to the above-described configuration of the present invention, it becomes easy to identify a substance in a living body tissue and measure its distribution by scanning a plurality of laser beams having different wavelengths in the visible to near-infrared light region. Further, according to such a measuring method, the types of substances that can be identified can be expanded with respect to the current situation, and in the tissue distribution measurement, the spatial resolution can be improved and the measurement time can be shortened.

実施例 以下、図面を用いて本発明の実施例の詳細を説明する。Embodiment Hereinafter, details of an embodiment of the present invention will be described with reference to the drawings.

ちなみに、光源として、GaInAs/A1GaAs系のレーザを併
せて用い、波長が900,1000nmの4点測定を行うと、コン
トラストがよくなる。これは波長範囲が拡大したため
に、異なる生体組織間での、散乱による減光量の差が明
瞭になるためである。また、脂肪は930nmに、水は970nm
に吸収線が存在し、この波長の光を用いることで、さら
に明瞭な組織の分布が得られるのは周知のとおりであ
る。
By the way, when a GaInAs / A1GaAs laser is also used as a light source and four-point measurement with wavelengths of 900 and 1000 nm is performed, the contrast is improved. This is because the difference in the amount of light extinction due to scattering between different living tissues becomes clear due to the expansion of the wavelength range. Also, fat is 930nm and water is 970nm.
It is well known that there is an absorption line in and a clearer tissue distribution can be obtained by using light of this wavelength.

第2図に示した従来の生体組織の計測システム、即ち、
発振波長が780nmのA1GaAs/GaAs系の半導体レーザと、発
振波長が632.8nmのHe−Neレーザとに加えて、本発明に
よる発振波長が900nmと1000nmのGaInAs/A1GaAs系半導体
レーザを併せて使用し、4点測定を行ったところ、高い
コントラストが得られた。これは、波長範囲が拡大した
ために、異る生体組織での散乱による減光量の差が大き
くなったためである。
The conventional biological tissue measuring system shown in FIG.
In addition to an A1GaAs / GaAs semiconductor laser with an oscillation wavelength of 780 nm and a He-Ne laser with an oscillation wavelength of 632.8 nm, a GaInAs / A1GaAs semiconductor laser with an oscillation wavelength of 900 nm and 1000 nm according to the present invention is used together. When four-point measurement was performed, high contrast was obtained. This is because the wavelength range is expanded and the difference in the extinction amount due to scattering in different living tissues is increased.

また、脂肪の吸収線は930nmに、水の吸収線は970nmにあ
る。したがって、これらの波長の光を用いることによっ
て、さらに明瞭な組織の分布を観測することが可能にな
る。
The absorption line of fat is at 930 nm and the absorption line of water is at 970 nm. Therefore, by using light of these wavelengths, a clearer tissue distribution can be observed.

さらに、A1GaInP/GaAs系の可視光の赤の領域の半導体レ
ーザ、InGaAsP/InP系の赤外半導体レーザを併せて用い
ると、さらに広い波長領域で、生体組織の光吸収、射の
波長依存の測定が可能になる。
Furthermore, by using the A1GaInP / GaAs-based semiconductor laser in the red region of visible light and the InGaAsP / InP-based infrared semiconductor laser together, the absorption of light in living tissue and the wavelength dependence of radiation can be measured in a wider wavelength range. Will be possible.

第1図は前述したような種々の光を得る本発明によるマ
ルチストライプ型のレーザの断面図であり、101は活性
層、102、103はクラッド層、1041…104nは複数の発光部
である。
FIG. 1 is a cross-sectional view of a multi-stripe type laser according to the present invention which obtains various kinds of light as described above, 101 is an active layer, 102, 103 are cladding layers, and 104 1 ... 104 n are a plurality of light emitting portions. .

この活性層はGaxIn1-xAsであり、第3図に示すように左
の方でIn組成が、0であり、右に向かって増加してい
く。この材料の場合、In組成の増加でバンドギャップは
減少し、レーザとしての発振波長は大きくなる。例え
ば、単一量子井戸構造では、量子井戸幅7nm、x=0.2.
で発振波長は約980nmとなる。また、ストライプの間隔
が200μmの場合、11個のストライプで2mmの幅となる。
生体測定では、組織内の散乱のため、光のビーム径は1
〜2mmで十分であるため、これで同一光源と見なせる。
勿論、必要に応じてIn組成の分布、ストライプの個数は
変化させて変えて使用する。
This active layer is GaxIn 1- xAs. As shown in FIG. 3, the In composition is 0 on the left side and increases toward the right. In the case of this material, the band gap decreases as the In composition increases, and the oscillation wavelength as a laser increases. For example, in a single quantum well structure, the quantum well width is 7 nm and x = 0.2.
The oscillation wavelength is about 980nm. When the stripe interval is 200 μm, 11 stripes have a width of 2 mm.
In the biometric measurement, the beam diameter of light is 1 because of scattering in the tissue.
Since ~ 2mm is sufficient, this can be regarded as the same light source.
Of course, the In composition distribution and the number of stripes may be changed and used as needed.

第2図に戻って、本発明のマルチストライプレーザ素子
で、発振波長が860〜1000nmまでの間で、等間隔で11の
波長が得られる素子を用いた測定例を示す。この範囲で
の脂肪と水の吸収線がそれぞれ930、970nmに存在してい
る。また、この領域での生体内の散乱は低く、数cmから
数十cmの厚さ(マウス、ウサギ、人の頭程度の、大き
さ)を透過した光を検出できる。このマルチストライプ
レーザを光源として、第2図のシステムで、乳ガンの検
査に用いると、数mm程度の腫瘍が、検査時間1分以内で
検出できる。
Returning to FIG. 2, a measurement example using the multi-striped laser device of the present invention, which has an oscillation wavelength of 860 to 1000 nm and can obtain 11 wavelengths at equal intervals, is shown. Absorption lines of fat and water in this range are present at 930 and 970 nm, respectively. In addition, scattering in the living body in this region is low, and light transmitted through a thickness of several cm to several tens of cm (a size of mouse, rabbit, or human head) can be detected. When this multi-striped laser is used as a light source for the examination of breast cancer in the system shown in FIG. 2, a tumor of several mm can be detected within the examination time of 1 minute.

発明の効果 以上のように本発明は、従来の光源では、輝度の不足、
もしくは使用できる光の波長が限られるために、実現が
困難であった生体組織物質の同定と、精細な分布測定が
容易になり、また、本発明による光源は輝度が高いため
に短時間で測定を終了できる。したがって、本発明によ
れば、例えば腫瘍の検診などの医療診断、生体組織内の
酸素濃度分布の生きた状態での観察などのような生体の
物質の観察に使用できる光学式測定方法をえることがで
きる。
EFFECTS OF THE INVENTION As described above, the present invention, in the conventional light source, lacks in brightness,
Alternatively, since the wavelength of light that can be used is limited, identification of a biological tissue substance, which has been difficult to realize, and fine distribution measurement are facilitated. Further, since the light source according to the present invention has high brightness, it can be measured in a short time. Can be finished. Therefore, according to the present invention, it is possible to obtain an optical measurement method that can be used for observing a substance in a living body such as medical diagnosis such as tumor screening and observing an oxygen concentration distribution in living tissue in a living state. You can

【図面の簡単な説明】[Brief description of drawings]

第1図は本発明の半導体発光装置を示し、(a)はその
断面図、(b)は活性層のIn組成を示す図、(c)はス
トライプ位置に対応した発光波長の変化を示す図であ
り、第2図は従来の生体組織の計測システムを示すブロ
ック図である。 101……活性層、102,103……クラッド層、1041から104n
……発光部。
FIG. 1 shows a semiconductor light emitting device of the present invention, (a) is a sectional view thereof, (b) is a diagram showing the In composition of an active layer, and (c) is a diagram showing changes in emission wavelength corresponding to stripe positions. FIG. 2 is a block diagram showing a conventional measuring system for biological tissues. 101 ... Active layer, 102, 103 ... Clad layer, 104 1 to 104n
...... Light emitting part.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】GaAsが基板であり、少なくとも活性層を構
成する材料がGaXIn1-XAs(0≦x≦0.5)であり、クラ
ッド層、オーミックコンタクト装を構成する材料がA1XG
a1-XAsである、可視領域の赤から、近赤外の波長領域で
発光する半導体発光装置を光源とし、この光源からの光
を生体に照射して、生体組織による光吸収、反射発光の
波長依存を計測することを特徴とする生体組織の光学的
計測方法。
1. A substrate made of GaAs, at least a material forming an active layer is Ga X In 1-X As (0 ≦ x ≦ 0.5), and a material forming a cladding layer and an ohmic contact device is A 1 X G
a 1-X As, a semiconductor light-emitting device that emits light in the visible to red to near-infrared wavelength range is used as the light source, and the light from this light source is applied to the living body to absorb and reflect light emitted by living tissue. An optical measurement method for living tissue, which comprises measuring the wavelength dependence of
【請求項2】GaAsが基板であり、(A1xGa1-X)yIn1-yP
(0≦x・y≦1)を構成材料とする発光装置であっ
て、クラッド層が、活性層に比べてバンドギャップの大
きさが略0.25eVだけ大きくかつ前記GaAs基板に格子整合
した組成である(A1×Ga1-x)0.5In0.5P(0≦x≦
1)である半導体発光装置を、可視領域の赤で発光する
計測用光源として用いることを特徴とする請求項1記載
の生体組織の光学的計測方法。
2. GaAs is the substrate, and (A1xGa 1-X ) yIn 1- yP
A light emitting device using (0 ≦ x · y ≦ 1) as a constituent material, wherein the clad layer has a band gap larger than that of the active layer by about 0.25 eV and has a composition lattice-matched to the GaAs substrate. Yes (A1 × Ga 1- x) 0.5 In 0.5 P (0 ≤ x ≤
2. The optical measuring method for a biological tissue according to claim 1, wherein the semiconductor light emitting device of 1) is used as a measuring light source that emits red light in the visible region.
【請求項3】InPが基板であり、InGaAsPを構成材料と
し、クラッド層が活性層に比べてバンドギャップの大き
さが略0.25eVだけ大きい半導体発光装置を計測用光源と
して用いることを特徴とする請求項1記載の生体組織の
光学的計測方法。
3. A semiconductor light emitting device, wherein InP is a substrate, InGaAsP is used as a constituent material, and a clad layer has a band gap larger than that of an active layer by about 0.25 eV as a light source for measurement. The optical measuring method of a biological tissue according to claim 1.
【請求項4】GaAsが基板であり、少なくとも活性層を構
成する材料がGaXIn1-XAs(0≦x≦0.5)であり、クラ
ッド層、オーミックコンタクト層を構成する材料がA1XG
a1-XGa1-XAsであり、可視領域の赤から近赤外の波長領
域で発光しかつ独立的に発光させることができる複数の
発光部を有する半導体発光装置であって、前記各発光部
の活性層間で前記活性層構成材料の組成比xが異ってお
り、前記発光部間で異る波長の光を発光させることを特
徴とする生体組織の計測用光源装置。
4. A substrate made of GaAs, at least a material forming an active layer is Ga X In 1-X As (0 ≦ x ≦ 0.5), and a material forming a cladding layer and an ohmic contact layer is A 1 X G
a 1-X Ga 1-X As, which is a semiconductor light-emitting device having a plurality of light-emitting units capable of emitting light in the visible to red wavelength region and the near-infrared wavelength region and independently emitting light. A light source device for measuring biological tissue, wherein composition ratios x of the active layer constituent materials are different between the active layers of the light emitting section, and light having different wavelengths is emitted between the light emitting sections.
【請求項5】発光部が同一光軸内とみなすことのできる
領域内に設置されていることを特徴とする請求項4記載
の生体組織の計測用光源装置。
5. The light source device for measuring a biological tissue according to claim 4, wherein the light emitting portion is installed in a region that can be regarded as within the same optical axis.
【請求項6】注入する電流の場所を変えることにより、
複数の前記発光部の発光波長を変化できる請求項4記載
の生体組織の計測用光源装置。
6. By changing the location of the injected current,
The light source device for measuring biological tissue according to claim 4, wherein the emission wavelengths of the plurality of light emitting units can be changed.
【請求項7】請求項4記載の光源装置を使用することに
より、生体組織の光吸収、反射、発光の波長の依存性を
計測することを特徴とする生体組織の光学的計測方法。
7. An optical measuring method of a biological tissue, which comprises measuring the wavelength dependence of light absorption, reflection and emission of the biological tissue by using the light source device according to claim 4.
JP14781890A 1990-06-06 1990-06-06 Optical measuring method of biological tissue and light source device for measuring the same Expired - Fee Related JPH0675033B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14781890A JPH0675033B2 (en) 1990-06-06 1990-06-06 Optical measuring method of biological tissue and light source device for measuring the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14781890A JPH0675033B2 (en) 1990-06-06 1990-06-06 Optical measuring method of biological tissue and light source device for measuring the same

Publications (2)

Publication Number Publication Date
JPH0440341A JPH0440341A (en) 1992-02-10
JPH0675033B2 true JPH0675033B2 (en) 1994-09-21

Family

ID=15438920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14781890A Expired - Fee Related JPH0675033B2 (en) 1990-06-06 1990-06-06 Optical measuring method of biological tissue and light source device for measuring the same

Country Status (1)

Country Link
JP (1) JPH0675033B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5812461B2 (en) * 2010-05-25 2015-11-11 国立大学法人名古屋大学 Biological tissue examination apparatus and examination method

Also Published As

Publication number Publication date
JPH0440341A (en) 1992-02-10

Similar Documents

Publication Publication Date Title
US5792051A (en) Optical probe for non-invasive monitoring of neural activity
JP3665061B2 (en) Quantitative and qualitative in vivo tissue analysis using time-resolved spectroscopy
US8027709B2 (en) Radiation probe and detecting tooth decay
US9116111B2 (en) Acoustic signal receiving apparatus and imaging apparatus
US8289502B2 (en) Measurement apparatus and measurement method
US6192260B1 (en) Methods and apparatus for examining tissue in vivo using the decay characteristics of scattered electromagnetic radiation
US5187672A (en) Phase modulation spectroscopic system
EP0627619B1 (en) Method for measuring scattering medium and apparatus for the same
Johnson Optical diffusion in blood
US5369496A (en) Noninvasive method and apparatus for characterizing biological materials
US7804075B2 (en) Method and system for tomographic imaging using fluorescent proteins
DE69313768T2 (en) Method and device for measuring optical information in a scattering medium
US20090312628A1 (en) Biological observation apparatus and method
EP0381883B1 (en) Optical examination apparatus
EP1683477B1 (en) Measuring method and apparatus of absorption information of scattering medium
US20060241395A1 (en) Device and method for locating an instrument within a body
JPH09219563A (en) Semiconductor optical device and application system using the same
DE3882274T2 (en) Examination device for measuring oxygen saturation.
Devaraj et al. Recent advances in coherent detection imaging (CDI) in biomedicine: laser tomography of human tissues in vivo and in vitro
TWI223719B (en) Sub-micrometer-resolution optical coherent tomography
JP4559995B2 (en) Tumor testing device
EP2027814A1 (en) Biological observation apparatus and method for obtaining information indicative of internal state of an object using sound wave and light
US20150085295A1 (en) Light emitting device and optical coherence tomography apparatus including same as light source
US20150263231A1 (en) Optical semiconductor device, driving method thereof, and optical coherence tomography apparatus having the optical semiconductor device
JPH0675033B2 (en) Optical measuring method of biological tissue and light source device for measuring the same

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees